Cargando…

Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States

The rapid development of commercially available molecular assays in response to the COVID-19 pandemic has been essential in identifying positive cases and guiding state and national response plans. With over 200 SARS-CoV-2 molecular tests having received emergency use authorization by the US Food an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Michelle R., Binnicker, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858713/ https://www.ncbi.nlm.nih.gov/pubmed/35636818 http://dx.doi.org/10.1016/j.cll.2022.02.001

Ejemplares similares

From the Common Cold to a Chaotic Contagion: the Potential for Coronaviruses To Cause Outbreaks of Severe Respiratory Disease Representing a Global Health Threat
por: Binnicker, Matthew J.
Publicado: (2020)

Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
por: Rodino, Kyle G., et al.
Publicado: (2022)

Multiplex PCR Assays for Identifying all Major Severe Acute Respiratory Syndrome Coronavirus 2 Variants
por: Dikdan, Ryan J., et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
por: Harcourt, Jennifer, et al.
Publicado: (2020)

Molecular Beacon Assay Development for Severe Acute Respiratory Syndrome Coronavirus 2 Detection
por: Carvalho, Josué, et al.
Publicado: (2021)

Analytical performance evaluation of five RT‐PCR kits for severe acute respiratory syndrome coronavirus 2
por: Wang, Mengmeng, et al.
Publicado: (2020)

Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests
por: Ashizawa, Nobuyuki, et al.
Publicado: (2021)

Analytical Performance of the Commercial MucorGenius(®) Assay as Compared to an In-House qPCR Assay to Detect Mucorales DNA in Serum Specimens
por: Ghelfenstein-Ferreira, Théo, et al.
Publicado: (2022)

Analytical Performance Evaluation of Three Commercial Rapid Nucleic Acid Assays for SARS-CoV-2
por: Yi, Jie, et al.
Publicado: (2021)

Testing for Cryptococcosis at a Major Commercial Laboratory—United States, 2019–2021
por: Benedict, Kaitlin, et al.
Publicado: (2022)

Comparative analytical evaluation of the respiratory TaqMan Array Card with real-time PCR and commercial multi-pathogen assays()
por: Harvey, John J., et al.
Publicado: (2016)

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
por: Gniazdowski, Victoria, et al.
Publicado: (2020)

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients
por: Wu, Shiji, et al.
Publicado: (2022)

Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children
por: Gharabaghi, F., et al.
Publicado: (2011)

Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays
por: Mostafa, Heba H., et al.
Publicado: (2020)

Enhanced rapid commercial DNA extraction kit for the molecular detection of severe acute respiratory syndrome coronavirus 2: Easy adaptation to current protocols
por: Pessoa-e-Silva, Rômulo, et al.
Publicado: (2021)

Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification
por: Orrù, Germano, et al.
Publicado: (2021)

Performance of three polymerase chain reaction-based assays for detection of SARS-CoV-2 in different upper respiratory tract specimens
por: Eberly, Allison R., et al.
Publicado: (2021)

Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response
por: Mylemans, Marnix, et al.
Publicado: (2021)

The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States
por: Otto, William R, et al.
Publicado: (2020)

Molecular biology of severe acute respiratory syndrome coronavirus
por: Ziebuhr, John
Publicado: (2004)

Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Uprety, Priyanka, et al.
Publicado: (2021)

Comparison of 12 Molecular Detection Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Matsumura, Yasufumi, et al.
Publicado: (2021)

Evaluation of the Serologic Cross-Reactivity between Transmissible Gastroenteritis Coronavirus and Porcine Respiratory Coronavirus Using Commercial Blocking Enzyme-Linked Immunosorbent Assay Kits
por: Magtoto, Ronaldo, et al.
Publicado: (2019)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study
por: Christenson, R.H., et al.
Publicado: (2019)

Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
por: Uhteg, Katharine, et al.
Publicado: (2020)

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021)

Performance of a rapid multi-analyte 2-photon excitation assay in children with acute respiratory infection()()()
por: Brotons, Pedro, et al.
Publicado: (2014)

Distinct differences in analytical performance of two commercially available assays for specific IgE to egg white and house dust mite allergens
por: Ito, Komei, et al.
Publicado: (2021)

Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports
por: Emeribe, Anthony Uchenna, et al.
Publicado: (2021)

Evaluation of three commercial multiplex assays for the detection of respiratory viral infections
por: Radko, Sandi, et al.
Publicado: (2017)

Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples
por: Liotti, Flora Marzia, et al.
Publicado: (2020)

Association between Preferred Language and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children in the United States
por: Otto, William R., et al.
Publicado: (2021)

Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing for Obstetric Inpatient Units Across the United States
por: Gilner, Jennifer, et al.
Publicado: (2021)

The phytochemical diversity of commercial Cannabis in the United States
por: Smith, Christiana J., et al.
Publicado: (2022)

Analytical and Clinical Validation of Six Commercial Middle East Respiratory Syndrome Coronavirus RNA Detection Kits Based on Real-Time Reverse-Transcription PCR
por: Kim, Mi-Na, et al.
Publicado: (2016)

Evaluation of the basic assay performance of the GeneSoc(®) rapid PCR testing system for detection of severe acute respiratory syndrome coronavirus 2
por: Watanabe, Ryosuke, et al.
Publicado: (2021)

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel
por: Tande, Aaron J, et al.
Publicado: (2022)

xTAG™ RVP assay: analytical and clinical performance
por: Krunic, Nancy, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_44knd5qnm7svc1l4idpt2qhveh